Literature DB >> 16467872

Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells.

Howard A Young1, John Ortaldo.   

Abstract

Cytokines are involved in directing the activation of natural killer (NK) cells. NK cells are involved in the recognition of cells that have been altered; thus they do not recognize specific insults to the host, but when activated, are capable of destroying infected cells directly, as well as promoting the recruitment and response of the other components of the immune system by the release of cytokines and chemokines. It is these properties that have made NK cells a critical part of innate immunity and adaptive immunity, and they play a principal role linking innate and adaptive immunity by the recruitment of an adaptive immune response to an innate immune reaction.

Mesh:

Substances:

Year:  2006        PMID: 16467872     DOI: 10.1038/sj.cr.7310004

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  14 in total

1.  Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.

Authors:  Raymond T Chung; Michael Gale; Stephen J Polyak; Stanley M Lemon; T Jake Liang; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

2.  Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.

Authors:  Tae-Don Kim; Su Ui Lee; Sohyun Yun; Hu-Nan Sun; Suk Hyung Lee; Jae Wha Kim; Hwan Mook Kim; Song-Kyu Park; Chang Woo Lee; Suk Ran Yoon; Philip D Greenberg; Inpyo Choi
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

3.  Immunological mechanism of the low-dose radiation-induced suppression of cancer metastases in a mouse model.

Authors:  Ewa M Nowosielska; Aneta Cheda; Jolanta Wrembel-Wargocka; Marek K Janiak
Journal:  Dose Response       Date:  2009-12-10       Impact factor: 2.658

Review 4.  Use of allogeneic NK cells for cancer immunotherapy.

Authors:  Melissa A Geller; Jeffrey S Miller
Journal:  Immunotherapy       Date:  2011-12       Impact factor: 4.196

5.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

6.  Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia.

Authors:  Kevin N Couper; Daniel G Blount; Julius C R Hafalla; Nico van Rooijen; J Brian de Souza; Eleanor M Riley
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

7.  Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.

Authors:  Sri Vidya Kondadasula; Julie M Roda; Robin Parihar; Jianhua Yu; Amy Lehman; Michael A Caligiuri; Susheela Tridandapani; Richard W Burry; William E Carson
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

Review 8.  MicroRNA function in NK-cell biology.

Authors:  Aimee M Beaulieu; Natalie A Bezman; Jang Eun Lee; Mehrdad Matloubian; Joseph C Sun; Lewis L Lanier
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

9.  Effect of low doses of low-let radiation on the innate anti-tumor reactions in radioresistant and radiosensitive mice.

Authors:  Ewa M Nowosielska; Aneta Cheda; Jolanta Wrembel-Wargocka; Marek K Janiak
Journal:  Dose Response       Date:  2012-08-30       Impact factor: 2.658

10.  Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells.

Authors:  Muxin Yu; Hong Pan; Nan Che; Li Li; Cong Wang; Yue Wang; Ge Ma; Mengjia Qian; Jiawei Liu; Mingjie Zheng; Hui Xie; Lijun Ling; Yi Zhao; Xiaoxiang Guan; Qiang Ding; Wenbin Zhou; Shui Wang
Journal:  Cell Mol Immunol       Date:  2020-05-08       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.